Summary
Johnson & Johnson (JNJ) filed an 8-K on October 18, 2016, to report its third-quarter financial results for the period ended October 2, 2016. The filing primarily consists of a press release detailing the company's sales and earnings performance. Investors can look to this report for an update on JNJ's operational and financial condition during the most recent quarter. The included supplementary data provides unaudited comparative sales figures and condensed consolidated statements of earnings, allowing for a more detailed analysis of the quarter's financial outcomes.
Key Highlights
- 1Johnson & Johnson reported its third-quarter 2016 financial results, ending October 2, 2016.
- 2The 8-K filing includes a press release announcing the company's sales and earnings.
- 3Investors can review unaudited comparative supplementary sales data.
- 4The report contains condensed consolidated statements of earnings for the third quarter.
- 5This filing serves as the official disclosure of JNJ's operational and financial performance for the period.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide Johnson & Johnson's sales and earnings results for the third quarter ended October 2, 2016, along with supporting financial data.
The specific financial details, including sales and earnings, are provided in the attached press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2O) included with the 8-K filing.
No, this 8-K filing primarily contains unaudited financial information, specifically the press release and supplementary sales and earnings data for the third quarter.